Belo Horizonte, Brazil

Mauro Martins Teixeira

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mauro Martins Teixeira: Innovator in IL-8 Inhibitors

Introduction

Mauro Martins Teixeira is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target bacterial infections. His work is crucial in advancing treatment options for patients suffering from secondary infections.

Latest Patents

Mauro holds a patent for "IL-8 inhibitors for use in the treatment and/or prevention of bacterial secondary infections." This invention focuses on IL-8 inhibitor compounds, specifically dual CXCR1/CXCR2 receptor inhibitors. These compounds are designed to be effective in treating and preventing secondary bacterial infections, with a particular emphasis on secondary respiratory infections. He has 1 patent to his name.

Career Highlights

Mauro is currently employed at Dompe' Farmaceutici S.p.a., a company known for its innovative pharmaceutical solutions. His role at the company allows him to contribute to the development of new therapies that can improve patient outcomes.

Collaborations

Mauro collaborates with talented professionals in his field, including Laura Brandolini and Marcello Allegretti. These partnerships enhance the research and development process, leading to more effective solutions in the pharmaceutical industry.

Conclusion

Mauro Martins Teixeira is a dedicated inventor whose work on IL-8 inhibitors represents a significant advancement in the treatment of bacterial infections. His contributions to the pharmaceutical field are invaluable, and his ongoing research promises to benefit many patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…